Promising roles of erythropoietin and lymphotoxin alpha in critical illness : a pilot study in critically ill children

الملخص EN

Background : Several studies proved the anti-inflammatory role of erythropoietin.

Little is known about the anti-inflammatory role of lymphotoxin alpha (LT-a).

This study was designed to investigate the patterns of erythropoietin (EPO) and LT-a levels in children with acute critical illness.

Patients and methods : Thirty-two critically ill children were prospectively subjected to serial estimation of EPO and LT-a levels, during the first 10 days of admission to one of the pediatric intensive care unit of Cairo University.

Thirteen healthy children served as control.

Results : Serial EPO and LT-a measurements showed significant increases over time early in their critical illness (P < 0.001, respectively).

Both cytokines showed significant increases in survivors (P < 0.001, respectively).

Kaplan Meier survival analysis revealed a significant increase in mortality with LT-a levels below 108.7 pg/ml, (P < 0.01) on admission.

However, EPO did not show any significant difference between survivors and non-survivors.

For both LT-a and EPO, levels at day 1 showed a significant decrease in septic patients.

EPO levels were significantly elevated on day 1 of admission in non-anemic [mean hemoglobin level (11.8 ± 0.9) g/dL, mean EPO level (110.85 ± 44.5) mIU/ml] compared with anemic patients [mean hemoglobin level (9.3 ± 1.3) g/dL, mean EPO level (69.84 ± 30.763) mIU/ml], 95% CI [13.896–68.112], P < (0.01).

Conclusions : Both EPO and LT-a showed significant increment in critically ill children especially in survivors.

Our data strongly suggest that, LT-a may have an anti-inflammatory role in children with acute critical illness.